Investigational Site Number : 7520002

Uppsala 752 37

2 studies enrolling now · 3 studies all time

What they study most

Hidradenitis Suppurativa, Immunoglobulin G4 Related Disease, Transplant Rejection

Studies at this site

• A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease — Recruiting now
• A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa — Recruiting now
• BIVV020 (SAR445088) in Prevention and Treatment of Antibody-mediated Rejection (AMR) — Running, not enrolling